Climb Bio, Inc. (CLYM) vs OmniAb, Inc. (OABI)
A side-by-side comparison of Climb Bio, Inc. and OmniAb, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLYM
Climb Bio, Inc.
$11.00HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
OABI
OmniAb, Inc.
$4.48HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — CLYM vs OABI
growth of $100 · dividends reinvested · last 2yCLYM +41.1% (+18.8%/yr)OABI +19.7% (+9.4%/yr)CLYM compounded faster over this window
CLYM OABI
CLYM vs OABI: by the numbers
- •OABI is the larger company ($649M vs $630M market cap).
- •Both run net losses; CLYM's is the smaller (0.00% vs -115.18% net margin).
Metrics side by side
Valuation
| Metric | CLYM | OABI |
|---|---|---|
| P/S ratio | N/A | 16.90 |
| P/B ratio | 2.63 | 2.50 |
Profitability
| Metric | CLYM | OABI |
|---|---|---|
| Gross margin | 0.00% | -18.17% |
| Operating margin | 0.00% | -383.15% |
| Net margin | 0.00% | -115.18% |
| ROE | -24.06% | -17.01% |
| ROIC | -26.94% | -17.48% |
Growth (annualized)
| Metric | CLYM | OABI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -4.31% |
| Total return CAGR (5Y) | N/A | -13.17% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.